Check out the priceless reaction from this USPS driver after he noticed snacks left behind by the homeowner. Amazing!
Check out the priceless reaction from this USPS driver after he noticed snacks left behind by the homeowner. Amazing!
Stock futures sank Tuesday morning, with the Nasdaq looking to add to losses as technology stocks came under increasing selling pressure as inflation concerns rose.
The "Sustainable Packaging - A full Shift to Paper and Bioplastics is neither Viable nor Sustainable" report has been added to ResearchAndMarkets.com's offering.
The "Global Spinal Muscular Atrophy Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
OPEC on Tuesday stuck to its prediction of a strong recovery in world oil demand in 2021 as growth in China and the United States counters the coronavirus crisis in India, an outlook that bolsters the group's plan to gradually ease output cuts. The oil organisation, however, cut its demand forecast for the second quarter by 300,000 bpd. "India is currently facing severe COVID-19-related challenges and will therefore face a negative impact on its recovery in the second quarter, but it is expected to continue improving its momentum again in the second half of 2021," OPEC said in its monthly report.
The Fox News host revved up his rage machine for the lamest attack yet on the infectious disease expert.
Top Players Covered in the Dermal Fillers Market Research Report Are Anika Therapeutics Inc. (Massachusetts, U.S.), Suneva Medical (California, U.S.), Prollenium Medical Technologies (Toronto, Canada), DR. Korman (Kiryat Bialik, Isreal), SCULPT Luxury Dermal Fillers LTD. (U.K), Bioxis Pharmaceuticals (Lyon, France), BIOPLUS CO. LTD. (South Korea), Sun Pharmaceutical Industries Ltd (Mumbai, India), Sinclair Pharma (London, U.K.), Galderma (Lausanne, Switzerland), Merz Pharma (Frankfurt, Germany), Revance Therapeutics Inc. (California, U.S.), ALLERGAN (Dublin, Ireland) and other key market players.Pune, India, May 11, 2021 (GLOBE NEWSWIRE) -- Dermal Fillers Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2027 is latest study published by Fortune Business Insights. The global dermal fillers market size is likely to reach USD 6.64 billion by 2027, registering a CAGR of 9.3% during the forecast period. Dermal fillers are used to regain the volume and bounce of facial skin. They are gel-like substances that are injected into the skin in cosmetic procedures. Fortune Business Insights™ has presented this information in an upcoming report titled, “Dermal Fillers Market, 2020-2027”. The market size stood at USD 3.73 billion in 2019. The report divulges the several factors influencing the market growth. For instance, the rising awareness amongst the geriatric population for minimal meddling techniques is significantly fueling the demand filler market growth. Since 2000, the number of minimal meddling cosmetic procedures has risen by almost 200%, according to the American Society of Plastic Surgeons data. COVID-19 Impact- The global pandemic has dismantled the operational infrastructure of several industries and markets, including the Dermal Fillers Market. Hindered by the lockdowns, social distancing norms, and curfews, the massive disturbances in the operations and the supply chain networks can be witnessed hampering the market’s growth. The global impact of the COVID-19 crisis is expected to gradually fade away as economies are trying to wade their way through the pandemic. Due to virtual consultations, the cosmetology, and dermatology sectors, the market is slowly gaining traction. It is uncertain to say how long the situation may persist this way. Nonetheless, our research report’s in-depth analysis will help you gain valuable insights into this niche market. Key Players in the Global Dermal Fillers Market: Anika Therapeutics Inc. (Massachusetts, U.S.)Suneva Medical (California, U.S.)Prollenium Medical Technologies (Toronto, Canada)DR. Korman (Kiryat Bialik, Isreal)SCULPT Luxury Dermal Fillers LTD. (U.K)Bioxis Pharmaceuticals (Lyon, France)BIOPLUS CO. LTD. (South Korea)Sun Pharmaceutical Industries Ltd (Mumbai, India)Sinclair Pharma (London, U.K.)Galderma (Lausanne, Switzerland)Merz Pharma (Frankfurt, Germany)Revance Therapeutics Inc. (California, U.S.)ALLERGAN (Dublin, Ireland) Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939 Global Dermal Fillers Market Highlights: The Dermal Fillers Market report offers an in-depth analysis of the Dermal Fillers industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Dermal Fillers market concentration, and maturity analysis is elaborated in this report. Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers. Segmentation- On the basis of material, the market segments into calcium hydroxylapatite, hyaluronic acid, poly-L-Lactic acid, fat fillers, PMMA (Polymethyl Methacrylate), etc. On the basis of product, the market bifurcates into non-biodegradable and biodegradable. On the basis of its application, the market divides into lip enhancement, scar treatment, restoration of volume/fullness, wrinkle correction treatment, etc. On the basis of its end-user, the market segments into hospital & clinics, specialty & dermatology clinics, etc. Geographically, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global Dermal Fillers Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry. Report Coverage- The report is based on historical data and follows top-down and bottom-up approaches for an infallible forecast of the market. The report incorporates Porters’ five Forces Analysis for a precise prediction. The report contains data gathered through interviews with multiple stakeholders at global, regional, and country levels. The report also studies the political, social, economic, technological, and environmental factors promoting the growth of the market in several regions. The report also contains information on the competitive landscape of the prospected market, including the data on new product launches, key market trends, alliances, acquisitions, mergers, etc. This report focuses on Dermal Fillers Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market. Click here to get the short-term and long-term impact of COVID-19 on this Dermal Fillers Market. Please visit: https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939 Drivers & Restraints- Escalating Demand for Painless and Easy Cosmetic Procedures to Propel Market Growth People are getting more conscious about their youthful appearance. They are seeking easy and painless methods like filler injections, botulinum toxin injections, etc., to appear youthful and healthier. The demand for these minimally invasive methods and cosmetic surgeries has escalated drastically over the past few years. The escalating demand has urged manufactures and industrialists to launch new products. For instance, Revance Therapeutics signed a distribution agreement with TEOXANE SA. This will help Revance Therapeutics cater to the demand for RHA fillers. These factors are expected to fuel the Dermal Fillers Market growth in the forthcoming years.However, the high cost of filler injections and their side effects are expected to act as a hindrance to market growth. Quick Buy Dermal Fillers Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100939 Regional Insights- Asia Pacific to Exhibit the Highest Growth Rate North America is anticipated to dominate the global dermal fillers market growth due to multiple factors. The regional population is financially strong and is well acquainted with these cosmetic procedures. The region also accounts for a comparatively high number of these procedures. These factors are expected to augment the market growth in North America. Escalating R&D expenditure, rising senior population, and an increasing number of individuals coming in for these filler procedures are expected to help Europe attain the second-highest rate of market growth.Increasing awareness regarding the enhancement of their physical appearance amongst individuals in Asian countries, health infrastructure progress, and the growing senior population is amongst the key factors that are expected to help the Asia Pacific exhibit the highest CAGR in the forecast period.Expanding health tourism is expected to help the Middle East & Africa, and Latin America witness moderate growth in the forthcoming years. Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermal-fillers-market-100939 Competitive Landscape- New Product Launches and Expansions to Intensify Competition The Dermal Fillers Market is fairly competitive and features three companies that possess the majority of shares in the worldwide facial filler market. The three companies, i.e., Allergan (AbbVie), Merz Pharma, and Galderma, have created a strong market presence. These companies are expected to significantly bolster market growth with their strategic moves. For instance, a new R&D-focused plant in Ireland was inaugurated by Allergan in January 2020. Industry Developments- August 2020: Revance Therapeutics Inc. launched the first and the only dermal filler approved by FDA. Known as the RHA Dermal Filler Line, these fillers will facilitate facial wrinkle correction.February 2020: BioScience GmbH introduced their new injectable line named Hyaprof combines polydensified and monodensified fillers. Table of Content from Dermal Fillers Market: Introduction Research ScopeMarket SegmentationResearch MethodologyDefinitions and Assumptions Executive SummaryMarket Dynamics Market DriversMarket RestraintsMarket Opportunities Key Insights Overview of the Number of Dermal Fillers Procedures by Key CountriesOverview of Price Analysis of Types of Dermal FillersOverview of Regulatory Scenario by Key CountriesOverview of Reimbursement Scenario by Key CountriesNew Product LaunchesPipeline Analysis Global Dermal Fillers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / SummaryMarket Analysis, Insights and Forecast – By Ingredient Hyaluronic AcidCalcium HydroxylapatitePoly-L-lactic AcidPMMA (Poly(methyl methacrylate))Fat FillersOthers Market Analysis, Insights and Forecast – By Product BiodegradableNon-Biodegradable Market Analysis, Insights and Forecast – By Application Scar TreatmentWrinkle Correction TreatmentLip EnhancementRestoration of Volume/ FullnessOthers Market Analysis, Insights and Forecast – By End User Specialty & Dermatology ClinicsHospitals & ClinicsOthers Market Analysis, Insights and Forecast – By Region North AmericaEuropeAsia PacificLatin AmericaMiddle East & Africa North America Dermal Fillers Market Analysis, Insights and Forecast, 2015-2026 Key Findings / SummaryMarket Analysis – By Ingredient Hyaluronic AcidCalcium HydroxylapatitePoly-L-lactic AcidPMMA (Poly(methyl methacrylate))Fat FillersOthers Market Analysis – By Product BiodegradableNon-Biodegradable Market Analysis – By Application Scar TreatmentWrinkle Correction TreatmentLip EnhancementRestoration of Volume/ FullnessOthers Market Analysis – By End User Specialty & Dermatology ClinicsHospitals & ClinicsOthers Market Analysis – By Country U.S.Canada TOC Continued… Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dermal-fillers-market-100939 Have a Look at Related Reports: Trauma Implants Market Size, Share & Industry Analysis, By Product (Metal Plates & Screws, Pins/Wires, Nails & Rods, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026 Bone Growth Stimulator Market Size, Share and Industry Analysis By Product Type (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)), By Application (Spinal Fusion, Maxillofacial & Dental, Nonunion and Union Bone Fractures), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care), and Regional Forecast 2019-2026 Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026 Reading Glasses Market Size, Share & Industry Analysis, By Age Group (Less than 18 years, 18-64 years, and 65 years and above), By Type (Prescription Reading Glasses and OTC Reading Glasses), By Distribution Channel (Retail Stores, Online Sales Channels, Ophthalmol-ogy Clinics), and Regional Forecast, 2019-2026 Diabetes Treatment Devices Market Size, Share & Industry Analysis, By Product (Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others), By Distribution Channel (Institutional Sales, Retail Sales) and Regional Forecast, 2019-2026 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: email@example.comFortune Business Insights™LinkedIn | Twitter | Blogs Press Release: https://www.fortunebusinessinsights.com/press-release/dermal-fillers-market-9173
Britain will move to ban conversion therapy and provide more support to those in the LGBT community who have undergone the treatment, as part of its post-pandemic government agenda. Prime Minister Boris Johnson's government said measures would be brought forward to prevent these "abhorrent practices which can cause mental and physical harm", starting with a consultation on how best to protect people and how to eliminate coercive practices. Johnson's party has come under increasing pressure on the issue after former leader Theresa May vowed in 2018 to eradicate a procedure that aims to change or suppress someone's sexual orientation or gender identity.
INTERRENT REIT GROWTH STORY INTACT - REPORTS STRONG INCREASE IN FFO FOR Q1 2021
Net Revenue for the Quarter Up 23% to $58.5 million Gross Profit of $21.3 Million for the Quarter, Gross Margin up over 300 Basis Points Year-Over-Year Company Raises Full Year 2021 EBITDA Outlook AUSTIN, Texas, May 11, 2021 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced pasture-raised foods nationwide, today reported financial results for its first quarter ended March 28, 2021. “We had a terrific start to the year, which we believe demonstrates our ability to retain consumers who are initially attracted to our products and remain loyal because of our mission, values, and commitment to stakeholders,” said Russell Diez-Canseco, President and CEO, Vital Farms. “We saw solid growth in both retail distribution, which increased 13% year over year, to over 16,500 stores at the end of the first quarter, and household penetration for our pasture-raised eggs, which now stands at 4.1%, up 120 basis points over that same time period.” Diez-Canseco continued, “We are building an enduring brand, delivering on our growth strategy, and showing the world how to produce ethical food at scale. We are confident in the opportunities that remain ahead for us to reach even more households with our high-quality, pasture-raised products.” For the Three Months Ended March 28, 2021 Net revenue increased 23% to $58.5 million in the first quarter of 2021 compared to $47.6 million in the first quarter of 2020. Growth in net revenue in the first quarter of 2021 was driven primarily by volume increases to our distributors and retail partners, and distribution gains in new and existing customers. Gross profit was $21.3 million, or 36.4% of net revenue, in the first quarter of 2021, compared to $15.9 million, or 33.3% of net revenue, in the prior year period. The increase in gross margin was driven by improved offsize egg utilization, lower material costs on butter, and volume leverage over direct labor and overhead costs. These benefits were partially offset by higher promotional spending and increased material costs on conventional eggs. Income from operations in the first quarter of 2021 was $3.1 million compared to $2.9 million in the first quarter of the prior year. Net income was $3.5 million in the first quarter of 2021 compared to $1.9 million in the prior year period. Net income per diluted share was $0.08 compared to $0.05 per diluted share in the prior year quarter. Adjusted EBITDA was $4.7 million in the first quarter of 2021 compared to $3.8 million in the first quarter of 2020, primarily driven by volume increases to Vital Farms’ distributors and retail customers, expanded gross margin, and leverage over fixed operating costs. The increase was partially offset by higher selling, general and administrative expenses due to public company costs, as well as higher employee-related costs driven by increased headcount, and slightly higher marketing expenses. Adjusted EBITDA is a non-GAAP financial measure defined under “Non-GAAP Financial Measures,” and is reconciled to net income, its closest comparable GAAP measure, at the end of this release. Balance Sheet and Cash Flow Highlights Cash, cash equivalents and investment securities were $102.9 million as of March 28, 2021, and Vital Farms had no current or long-term debt outstanding as of March 28, 2021. Net cash provided by operating activities was $8.0 million in the first quarter ended March 28, 2021, compared to $0.8 million net cash provided by operating activities during the prior year period. Capital expenditures totaled $3.5 million for the first quarter ended March 28, 2021 compared to $4.3 million in the prior year period. Update on Fiscal 2021 Outlook Vital Farms’ guidance continues to assume that there are no additional, significant disruptions to the supply chain, its customers or consumers, including any issues from adverse macroeconomic factors. For the full fiscal year 2021, management is maintaining its net revenue expectations of $246 to $253 million, which represents an increase of 15 to 18% compared to 2020.Our forecast for Adjusted EBITDA has increased to a range of $7 to $9 million, relative to prior guidance of $6 to $8 million. Vital Farms cannot provide a reconciliation between its forecasted Adjusted EBITDA and net revenue metrics without unreasonable effort due to the unavailability of reliable estimates for certain items. These items are not within Vital Farms’ control and may vary greatly between periods and could significantly impact future financial results. Conference Call and Webcast DetailsVital Farms will host a conference call and webcast at 8:30 a.m. ET today to discuss the results. The live conference call webcast can be accessed on the Vital Farms Investor Relations website at https://investors.vitalfarms.com under “Events.” The webcast will also be archived and available for replay. About Vital Farms Vital Farms, a Certified B Corporation, offers a range of ethically produced pasture-raised foods nationwide. Started on a single farm in Austin, Texas, in 2007, Vital Farms is now a national consumer brand that works with over 200 small family farms and is the leading U.S. brand of pasture-raised eggs and butter by retail dollar sales. Vital Farms' ethics are exemplified by its focus on the humane treatment of farm animals and sustainable farming practices. In addition, as a Delaware Public Benefit Corporation, Vital Farms prioritizes the long-term benefits of each of its stakeholders, including farmers and suppliers, customers and consumers, communities and the environment, and crew members and stockholders. Vital Farms' pasture-raised products, including shell eggs, butter, hard-boiled eggs, ghee, egg bites and liquid whole eggs, are sold in over 16,500 stores nationwide. For more information, visit www.vitalfarms.com. Forward-Looking StatementsThis press release and the earnings call referencing this press release contain “forward-looking” statements, as that term is defined under the federal securities laws, including but not limited to statements regarding Vital Farms’ market opportunity, anticipated growth, and future financial performance, including management’s outlook for fiscal year 2021. These forward-looking statements are based on Vital Farms’ current assumptions, expectations and beliefs and are subject to substantial risks, uncertainties, assumptions and changes in circumstances that may cause Vital Farms’ actual results, performance or achievements to differ materially from those expressed or implied in any forward-looking statement. The risks and uncertainties referred to above include, but are not limited to: the effects of the current COVID-19 pandemic on Vital Farms’ supply chain, the demand for its products, and on overall economic conditions and consumer confidence and spending levels; Vital Farms’ expectations regarding its revenue, expenses and other operating results; Vital Farms’ ability to acquire new customers, to successfully retain existing customers and to attract and retain its suppliers, distributors and co-manufacturers; Vital Farms’ ability to sustain or increase our profitability; Vital Farms’ ability to procure sufficient high quality eggs, butter and other raw materials; real or perceived quality with Vital Farms’ products or other issues that adversely affect Vital Farms’ brand and reputation; changes in the tastes and preferences of consumers; the financial condition of, and Vital Farms’ relationships with, its suppliers, co-manufacturers, distributors, retailers and foodservice customers, as well as the health of the foodservice industry generally; the ability of Vital Farms’ suppliers and co-manufacturers to comply with food safety, environmental or other laws or regulations; future investments in its business, anticipated capital expenditures and estimates regarding capital requirements; the costs and success of marketing efforts. Vital Farms’ ability to effectively manage its growth and to compete effectively with existing competitors and new market entrants; the potential negative impact of Vital Farms’ focus on a specific public benefit purpose and producing a positive effect for society on its financial performance; seasonality; and the growth rates of the markets in which Vital Farms competes. These risks and uncertainties are more fully described in Vital Farms’ filings with the Securities and Exchange Commission, including in the section entitled “Risk Factors” in its Annual Report on Form 10-K for the fiscal year ended December 27, 2020 and other filings and reports that Vital Farms may file from time to time with the SEC. Moreover, Vital Farms operates in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for management to predict all risks, nor can Vital Farms assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements Vital Farms may make. In light of these risks, uncertainties and assumptions, Vital Farms cannot guarantee future results, levels of activity, performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. Forward-looking statements represent managements’ beliefs and assumptions only as of the date of this press release. Vital Farms disclaims any obligation to update forward-looking statements except as required by law. Contacts: Media:Nisha DevarajanNisha.Devarajan@vitalfarms.com Investors:Matt SilerMatt.Siler@vitalfarms.com VITAL FARMS, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Amounts in thousands, except share amounts) Fiscal Quarter Ended (Unaudited) March 28, 2021 March 29, 2020Net revenue$58,545 $47,579 Cost of goods sold 37,215 31,724 Gross profit 21,330 15,855 Operating expenses: Selling, general and administrative 13,183 9,678 Shipping and distribution 5,063 3,274 Total operating expenses 18,246 12,952 Income from operations 3,084 2,903 Other income (expense), net: Interest expense (18) (158)Other income, net 110 20 Total other income (expense), net 92 (138)Net income before income taxes 3,176 2,765 (Benefit) provision for income taxes (304) 831 Net income 3,480 1,934 Less: Net income attributable to noncontrolling interests (11) (11)Net income attributable to Vital Farms, Inc. common stockholders$3,491 $1,945 Net income per share attributable to Vital Farms, Inc. stockholders: Basic:$0.09 $0.07 Diluted:$0.08 $0.05 Weighted average common shares outstanding: Basic: 39,536,928 25,942,277 Diluted: 43,509,371 37,118,484 VITAL FARMS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(Amounts in thousands, except share amounts) March 28, 2021(Unaudited) December 27, 2020Assets Current assets: Cash and cash equivalents$35,101 $29,544 Investment securities available-for-sale 67,787 68,357 Accounts receivable, net 18,262 20,934 Inventories 11,280 12,902 Income taxes receivable 2,002 1,554 Prepaid expenses and other current assets 2,472 3,965 Total current assets 136,904 137,256 Property, plant and equipment, net 32,920 30,118 Goodwill 3,858 3,858 Deposits and other assets 142 142 Total assets$173,824 $171,374 Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Equity Current liabilities: Accounts payable$14,227 $15,489 Accrued liabilities 8,731 9,845 Lease obligation, current 476 471 Contingent consideration, current 87 109 Total current liabilities 23,521 25,914 Lease obligation, net of current portion 206 327 Contingent consideration, non-current 4 18 Deferred tax liabilities, net 2,680 2,537 Other liability, non-current 191 192 Total liabilities 26,602 28,988 Commitments and contingencies (Note 15) Redeemable noncontrolling interest 175 175 Stockholders’ equity: Common stock, $0.0001 par value per share, 310,000,000 shares authorized as of March 28, 2021 (unaudited) and December 27, 2020; 39,744,306 and 39,444,040 shares issued and outstanding as of March 28, 2021 (unaudited) and December 27, 2020, respectively 5 5 Treasury stock, at cost, 5,494,918 common shares as of March 28, 2021 (unaudited) and December 27, 2020 (16,276) (16,276)Additional paid-in capital 145,689 144,311 Retained earnings 17,530 14,039 Accumulated other comprehensive loss (53) (31)Total stockholders’ equity attributable to Vital Farms, Inc. stockholders 146,895 142,048 Noncontrolling interests 152 163 Total stockholders’ equity 147,047 142,211 Total liabilities, redeemable noncontrolling interest, and stockholders’ equity$173,824 $171,374 VITAL FARMS, INC.CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS(Amounts in thousands) 13-Weeks Ended (Unaudited) March 28, 2021 March 29, 2020Cash flows provided by operating activities: Net income$3,480 $1,934 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 785 456 Bad debt recovery (45) (116)Stock-based compensation expense 853 448 Deferred taxes 142 413 Other (58) 75 Changes in operating assets and liabilities: Accounts receivable 2,717 (2,953)Inventories 1,636 726 Income taxes receivable (449) 413 Prepaid expenses and other current assets 1,492 619 Deposits and other assets — (27)Accounts payable (1,402) 1,434 Accrued liabilities and other liabilities (1,111) (2,575)Net cash provided by operating activities$8,040 $847 Cash flows used in investing activities: Purchases of property, plant and equipment (3,451) (4,269)Purchases of available-for-sale debt securities (14,409) — Sales, maturities, and call redemptions of available-for-sale debt securities 15,010 — Net cash used in investing activities$(2,850) $(4,269)Cash flows provided by financing activities: Proceeds from borrowings under term loan — 3,907 Proceeds from borrowings under equipment loan — 1,461 Repayment of equipment loan — (49)Repayment of term loan — (168)Payment of contingent consideration (42) (47)Payment of deferred offering costs — (1,145)Principal payments under finance lease obligation (116) (110)Proceeds from exercise of stock options 525 10 Net cash provided by financing activities$367 $3,859 Net increase in cash and cash equivalents$5,557 $437 Cash and cash equivalents at beginning of the period 29,544 1,274 Cash and cash equivalents at end of the period$35,101 $1,711 Supplemental disclosure of cash flow information: Cash paid for interest$20 $136 Cash paid for income taxes — 5 Supplemental disclosure of non-cash investing and financing activities: Purchases of property, plant and equipment included in accounts payable and accrued liabilities$140 $— Deferred offering costs in accounts payable and accrued liabilities$— $444 Non-GAAP Financial Measures Vital Farms reports its financial results in accordance with GAAP. However, management believes that Adjusted EBITDA, a non-GAAP financial measure, provides investors with additional useful information in evaluating Vital Farms’ performance. Vital Farms calculates Adjusted EBITDA as net income, adjusted to exclude: (1) depreciation and amortization; (2) provision for income taxes; (3) stock-based compensation expense; (4) interest expense; (5) interest income; (6) change in fair value of contingent consideration; and (7) net litigation settlement gain. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with GAAP. Management believes that Adjusted EBITDA, when taken together with Vital Farms’ financial results presented in accordance with GAAP, provides meaningful supplemental information regarding Vital Farms’ operating performance and facilitates internal comparisons of Vital Farms’ historical operating performance on a more consistent basis by excluding certain items that may not be indicative of its business, results of operations or outlook. In particular, management believes that the use of Adjusted EBITDA is helpful to Vital Farms’ investors as it is a measure used by management in assessing the health of the business, determining incentive compensation and evaluating Vital Farms’ operating performance, as well as for internal planning and forecasting purposes. Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA include that (1) it does not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures, (3) it does not consider the impact of stock-based compensation expense, (4) it does not reflect other non-operating expenses, including interest expense, (5) it does not consider the impact of any contingent consideration liability valuation adjustments and (6) it does not reflect tax payments that may represent a reduction in cash available to Vital Farms. In addition, Vital Farms’ use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as a comparative measure. Because of these limitations, when evaluating Vital Farms’ performance, investors should consider Adjusted EBITDA alongside other financial measures, including Vital Farms’ net income and other results stated in accordance with GAAP. The following table presents a reconciliation of Adjusted EBITDA to net income, the most directly comparable financial measure stated in accordance with GAAP, for the periods presented: VITAL FARMS, INC.ADJUSTED EBITDA RECONCILIATION(Amounts in thousands) Fiscal Quarter Ended March 28, 2021 March 29, 2020Net income (loss)$3,480 $1,934 Depreciation and amortization 785 456 (Benefit) Provision for income tax (304) 831 Stock-based compensation expense 853 448 Interest expense 18 158 Change in fair value of contingent consideration (1) 6 (23)Interest income (97) (5)Adjusted EBITDA$4,741 $3,799 (1) Amount reflects the change in fair value of a contingent consideration liability in connection with our 2014 acquisition of certain assets of Heartland Eggs
The "Key Trends in Business Travel (2021)" report has been added to ResearchAndMarkets.com's offering.
Britain set out plans to crack down on hostile activity by foreign states on Tuesday, introducing a proposed law to give security services and law enforcement new powers to tackle growing threats. The bill will haul legislation into the modern age, updating archaic official secrets acts, some dating back more than hundred years, so that they are relevant to the threats posed in the age of cyber warfare, the government said. British spy chiefs say both China and Russia have sought to steal commercially sensitive data and intellectual property as well as to interfere in politics, while Russian agents are also accused of carrying out an attack on former Russian spy Sergei Skripal on British soil in 2018.
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "RNA-based Therapeutics and Vaccines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global RNA-based Therapeutics and Vaccines Market to Reach $499 Million by 2027Amid the COVID-19 crisis, the global market for RNA-based Therapeutics and Vaccines estimated at US$14.7 Million in the year 2020, is projected to reach a revised size of US$499 Million by 2027, growing at a CAGR of 65.5% over the period 2020-2027. RNA-based Therapeutics, one of the segments analyzed in the report, is projected to record 68.1% CAGR and reach US$372.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RNA-based Vaccines segment is readjusted to a revised 59.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $4.5 Million, While China is Forecast to Grow at 62% CAGRThe RNA-based Therapeutics and Vaccines market in the U.S. is estimated at US$4.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$76.6 Million by the year 2027 trailing a CAGR of 62% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 59.2% and 55.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 43.7% CAGR.Key Topics Covered: I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market InsightsWorld Market TrajectoriesImpact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS(Total 41 Featured): Alnylam Pharmaceuticals, Inc.Arbutus Biopharma CorporationArrowhead Pharmaceuticals, Inc.BioNTech AGCureVac AGDicerna Pharmaceuticals, Inc.Marina Biotech, Inc.miRagen Therapeutics, Inc.Moderna, Inc.Quark Pharmaceuticals, Inc.Regulus Therapeutics, Inc.Sylentis S.A. 3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE World Current & Future Analysis for RNA-based Therapeutics and Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for RNA-based Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for RNA-based Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGRWorld Current & Future Analysis for Genetic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR III. GEOGRAPHIC MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 41 For more information about this report visit https://www.researchandmarkets.com/r/z3902r CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Key Companies Covered in Network Security Market Research Report are Check Point Software Technologies Ltd., Cisco Systems, Inc., FireEye, Inc., Fortinet, Inc., Juniper Networks, Inc., Kaspersky Lab., McAfee, LLC, Palo Alto Networks, Inc., SonicWall.com, WatchGuard Technologies, Inc.Pune, India, May 11, 2021 (GLOBE NEWSWIRE) -- The global network security market size is projected to reach USD 60.38 billion by 2028, exhibiting a CAGR of 12.0% during the forecast period. Fortune Business Insights™ shares this information in its report, titled “Network Security Market, 2021-2028”. As per the report, the value of the market stood at USD 24.88 billion in 2020. As the business world is becoming a smaller place backed by the rapidly expanding digital network among enterprises, the increasing rate of cyberattacks has become a concerning matter globally. According to an in-depth study by Proofpoint on user awareness, more than 88% of firms worldwide have been a victim of phishing attempts in 2019. Expanding Work-from-home Infrastructure amid COVID-19 to Augment Growth The COVID-19 pandemic has been a buffet for cybercriminals as a lot of companies have been vulnerable during the first quarter of the pandemic. The key reason has been a change in the workstyle of employees, which is a rapid increase in the work-from-home settings. This has encouraged employers to implement network security services, which is projected to enhance the growth of the market. Based on our key findings, the market has experienced a positive growth of 9.6% in 2020 and is predicted to secure a market value of USD 27.39 billion in 2021. Click here to get the short-term and long-term impact of COVID-19 on this market. Please visit: https://www.fortunebusinessinsights.com/enquiry/queries/network-security-market-100339 Market Segmentation We have categorized the market on the basis of type, development, enterprise size, industry, and geography. In terms of type, the market is divided into firewalls, antivirus and anti-malware software, VPN, wireless security, and others (data loss prevention, intrusion prevention systems). Based on development, the market is segmented into cloud and on premise. Based on enterprise size, it is fragmented into small & medium sized enterprises and large enterprises. In terms of industry, the market is divided into BFSI, IT and telecommunications, retail, healthcare, government, manufacturing, travel and transportation, energy and utilities, and others (education). Lastly, on the basis of region, it is segmented into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. Request To Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/network-security-market-100339 What Does the Report Offer? In order to prepare this report, we have captured data on the revenue of several key players through secondary sources such as company websites, corporate filings, annual reports, and investor presentations. We have conducted extensive interviews with key industry experts, such as CEOs, VPs, directors, and executives in order to track and analyze competitive developments such as partnerships, mergers & acquisitions, new product launches, and research & development activities. Our next step included bottom-up procedure to arrive at the overall size of the market. Driving factor Rising Cases of Cyberattacks and Security Breached to Drive Growth The increasing cases of cyber-attacks and security breaches have compelled a majority of large and small companies to protect their networks. This is projected to drive the network security market growth. For instance, according to the identity Theft Resource Center, a total of 11,762 major security breaches have been registered from 2005 to 2020. In addition, the rapidly growing trend of Bring Your Own Devices (BYOD) policy by employers along with the increasing adoption of work from home settings amid the pandemic is estimated to boost the demand for network security solutions globally. Regional Insights Presence of Leading Technology Providers in the U.S. to Boost Demand in North America North America is estimated to dominate the network security market owing to the presence of major ICT companies in the U.S. The country is home to major data-driven enterprises including Amazon, Facebook, Microsoft, IBM, etc. Such companies require constant, effective network security services in order to run their operations smoothly. In addition, the increasing application of such services in the defense and military industry of the country is anticipated to propel the adoption. Such factors are projected to strengthen the market growth for network securities in the region. Europe is expected to hold a major market share market share during the forecast period. The European Commission has upgraded its cybersecurity strategy, which was originally launched in 2013, to enhance the protection of networks. This will boost the demand for network securities in the region. Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/network-security-market-100339 Competitive Landscape Strategic Partnerships to Help Key Enterprises Offer Products in Key Markets The global network security market comprises industry leaders focusing on safeguarding networks all around the world. Key players operating in the market are collaborating with fellow enterprises to tap new potential markets and expand their customer base. For instance, in February 2021, RAH Infotech, a leading networks and security solutions provider, announced partnership with FireEye, a cybersecurity enterprise from California. The company will help FireEye in selling and distributing its innovative security solutions in India. Industry Developments: In October 2019 – Fortinet Inc., a multinational cybersecurity developer based in the U.S., announced the acquisition of enSilo Inc. The acquisition will enable the company to strengthen its network and endpoint solutions for security. In January 2019 –McAfee, an industry leading antivirus developer and security expert, acquired Skyhigh Network, a leading cloud access security broker from California. The acquisition will help McAfee offer cloud-based solutions to its customers. List of Key Companies Covered in the Global Market: Check Point Software Technologies Ltd. (Tel Aviv-Yafo, Israel)Cisco Systems, Inc. (California, United States)FireEye, Inc. (Milpitas, California, United States)Fortinet, Inc. (Sunnyvale, California)Juniper Networks, Inc. (Sunnyvale, California)Kaspersky Lab. (Moscow, Russia)McAfee, LLC (California, United States)Palo Alto Networks, Inc. (Santa Clara, California)SonicWall.com (Milpitas, California, United States)WatchGuard Technologies, Inc. (Seattle, WA, United States) Quick Buy – Network Security Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100339 Detailed Table of Content Introduction Definition, By SegmentResearch Methodology/ApproachData Sources Key TakeawaysMarket Dynamics Macro and Micro Economic IndicatorsDrivers, Restraints, Opportunities and TrendsImpact of COVID-19 Short-term ImpactLong-term Impact Competition Landscape Business Strategies Adopted by Key PlayersConsolidated SWOT Analysis of Key Players Global Network Security Key Players Market Share Insights and Analysis, 2020 Key Market Insights and Strategic RecommendationsCompanies Profiled (Covered for key 10 players only) Overview Key ManagementHeadquarters etc. Offerings/Business SegmentsKey Details (Key details are subjected to data availability in public domain and/or on paid databases) Employee SizeKey Financials Past and Current RevenueGeographical ShareBusiness Segment Share Recent Developments TOC Continued… Have a Look at Related Research Insights: Property Management Market Size, Share & COVID-19 Impact Analysis, By Component (Software, Services), By Deployment (Cloud, On-Premises), By Application (Residential, Commercial), By End-User (Property Managers, Housing Associations, Real Estate Agents, and Others) and Regional Forecast, 2021-2028 Cloud Storage Market Size, Share & COVID-19 Impact Analysis, By Component (Storage Model, and Services), By Deployment (Private, Public, and Hybrid), By Enterprise Size (SMEs, and Large Enterprises), By Vertical (BFSI, IT and Telecommunication, Government and Public Sector, Manufacturing, Healthcare and Life Sciences, Retail and Consumer Goods, Media and Entertainment, and Others) and Regional Forecast, 2021-2028 Latin America Fraud Detection and Prevention Market Size, Share & COVID-19 Impact Analysis, By Component (Solutions and Services), By Application Area (Insurance Claims, Money Laundering), By Deployment (Cloud and On-Premise), By Enterprise Size (Large Enterprises and SMEs), By Vertical (BFSI, IT and Telecom, Retail and Consumer Packaged Goods, Government, Construction and Real Estate, Energy and Utilities), and Geographical Forecast, 2021-2028 Identity Theft Protection Services Market Size, Share & COVID-19 Impact Analysis, By Type (Credit Card Fraud, Bank Fraud, Phone or Utility Fraud, Employment or Tax-Related Fraud), By Application (Consumer, Enterprise), and Regional Forecast, 2021-2028 Media Monitoring Tools Market Size, Share & COVID-19 Impact Analysis, By Component (Software/Platform, Services), By Type (Print Media Monitoring, Broadcast Media Monitoring, Online Media Monitoring), By Deployment (Cloud, On-premises), By Enterprise Size (SMEs, Large Enterprises), By Application (Customer Experience & PR Management, Real-Time Analytics), By Industry (BFSI, Healthcare, Retail & eCommerce), and Regional Forecast, 2021-2028 About Us: Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: email@example.com LinkedIn: https://www.linkedin.com/company/fortune-business-insights Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd Twitter: https://twitter.com/FBInsightPvtLtd Read Press Release https://www.fortunebusinessinsights.com/press-release/network-security-market-9915
In response to a colleague who poked him in the eyebrow, a cook slashed the man’s forehead with a meat cleaver, causing his skull to be exposed.
The "Global Acne Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
Walt Disney (NYSE: DIS) was relying on theme park vacations, cruises, sports, and the movie industry for almost all of its business before the pandemic, and each came to a virtual standstill when it struck. Disney management pivoted quickly and created a television streaming segment that blossomed while its other businesses were on hold. Now that vaccinations have rolled out, things are opening back up and people are talking about more than just the streaming services.
Sega will release action-adventure game Lost Judgment on 24 September 2021 on PlayStation 5, PlayStation 4, Xbox Series X, Xbox Series S and Xbox One.
Uefa has been urged to prioritise fans over the "prawn sandwich" contingent of officials so the all-English Champions League Final can be hosted at Wembley. The biggest game in European football remains scheduled to take play in Istanbul on May 29 but last week the Government's put Turkey on its high-risk 'red list' for international travel, effectively ruling out fans being in attendance. Uefa are considering other options and held talks with Government officials on Monday though no agreement was reached, leading to Portugal now emerging as an alternative.
This bank is a leader in small-business lending, but its investments in fintech have me excited about its growth potential.
"Seriously, I can not even blink my eye"